Reactive |
Infectious mononucleosis* Other reactive lymphoid proliferations with prominent immunoblasts (eg, autoimmune diseases, viral infections, drug reactions)
|
Borderline | Usually indolent
May be aggressive
Polymorphic immunodeficiency-related lymphoproliferative disorders (Polymorphic ID-LPD)* (eg, polymorphic post-transplant lymphoproliferative disorder) Lymphomatoid granulomatosis (grades 1 and 2)
|
Neoplastic T cells |
Angioimmunoblastic T cell lymphoma* Follicular T cell lymphoma Nodal PTCL with T-follicular helper phenotype PTCL, NOS
|
Neoplastic B cells |
CHL* Nodular lymphocyte-predominant Hodgkin lymphoma* T-cell/histiocyte-rich large B cell lymphoma* EBV-positive DLBCL B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and CHL
|